![Leila Alland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leila Alland
Director/Board Member at
ABEONA THERAPEUTICS INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Leila Alland is currently an Independent Director at Abeona Therapeutics, Inc. since 2021 and a Director at Jubilant Therapeutics, Inc. since 2021.
Former roles include Independent Non-Executive Director at Radiopharm Theranostics Ltd. from 2022 to 2025, Director at Cytovia Therapeutics, Inc. from 2020 to 2022, Chief Medical Officer at Affimed NV from 2018 to 2019, Assistant Professor-Pediatrics at Albert Einstein College of Medicine, Inc. from 1994 to 2000, Vice President & Head-Oncology at AstraZeneca LP from 2013 to 2015, Chief Medical Officer at Tarveda Therapeutics, Inc. from 2016 to 2018, and Chief Medical Officer at PMV Pharmaceuticals, Inc. from 2019 to 2023.
Education includes undergraduate studies at the University of Pennsylvania and a doctorate from New York University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-14 | 173,614 ( 0.3% ) | 1 M $ | 2026-05-30 | |
| 2025-11-19 | 1,071,740 ( 0.03% ) | 15 422 $ | 2026-05-30 |
Leila Alland active positions
| Companies | Position | Start |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2021-04-18 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for oncology and autoimmune diseases | Director/Board Member | 2021-08-15 |
Former positions of Leila Alland
| Companies | Position | End |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Director/Board Member | 2025-11-19 |
| PMV PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2023-11-30 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Director/Board Member | 2022-01-31 |
| AFFIMED N.V. | Chief Tech/Sci/R&D Officer | 2019-11-29 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Chief Tech/Sci/R&D Officer | 2018-02-28 |
Training of Leila Alland
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for oncology and autoimmune diseases | Health Technology |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
- Stock Market
- Insiders
- Leila Alland
